Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 2,668 | 2,176 | 2,981 | 1,303 | 977 |
| Operating Income | -2,668 | -2,176 | -2,981 | -1,303 | -977 |
| Interest Expense | 0 | 0 | 574 | 248 | 388 |
| Other Income | 0 | 493 | -8,262 | 147 | -2,973 |
| Pre-tax Income | -2,668 | -1,683 | -11,817 | -1,404 | -4,338 |
| Net Income Continuous | -2,668 | -1,683 | -11,817 | -1,404 | -4,338 |
| Net Income | $-2,668 | $-1,683 | $-11,817 | $-1,404 | $-4,338 |
| EPS Basic Total Ops | -1,360.49 | -1,053.57 | -11,488.51 | -2,451.33 | -7,765.34 |
| EPS Basic Continuous Ops | -1,360.49 | -1,052.80 | -11,675.02 | -2,455.77 | -7,576.93 |
| EPS Diluted Total Ops | -1,360.49 | -1,053.57 | -11,488.51 | -2,451.33 | -7,765.34 |
| EPS Diluted Continuous Ops | -1,360.49 | -1,052.80 | -11,675.02 | -2,455.77 | -7,576.93 |
| EBITDA(a) | $-2,642 | $-2,150 | $-2,955 | $-1,277 | $-951 |